Carlyle's Ortho Clinical debuts after $1.3B listing
January 29, 2021
Ortho Clinical Diagnostics has raised more than $1.29 billion in its IPO, with shares of the company closing down about 5% in their first day on the Nasdaq. Based in New Jersey and backed by The Carlyle Group, the company is a provider of in vitro diagnostic testing services used by hospitals, blood banks, labs and more. Carlyle acquired Ortho Clinical in a $4 billion deal in 2014.